Differentiation of human pluripotent stem cells toward pancreatic beta cells yields cells of increased maturity.
References
Assady, S. et al. Diabetes 50, 1691–1697 (2001).
Kroon, E. et al. Nat. Biotechnol. 26, 443–452 (2008).
Hebrok, M. Cold Spring Harb. Perspect. Med. 2, a007674 (2012).
Rezania, A. et al. Nat. Biotechnol. 32, 1121–1133 (2014).
Barton, F.B. et al. Diabetes Care 35, 1436–1445 (2012).
Jennings, R.E. et al. Diabetes 62, 3514–3522 (2013).
Mukhi, S., Horb, M.E. & Brown, D.D. Dev. Biol. 328, 384–391 (2009).
Aguayo-Mazzucato, C. et al. Diabetes 62, 1569–1580 (2013).
Stanger, B.Z. & Hebrok, M. Gastroenterology 144, 1170–1179 (2013).
Rezania, A. et al. Diabetes 61, 2016–2029 (2012).
Solar, M. et al. Dev. Cell 17, 849–860 (2009).
Rezania, A. et al. Diabetes 60, 239–247 (2011).
Blum, B. et al. eLife 3, e02809 (2014).
Pagliuca, F.W. et al. Cell 159, 428–439 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Hanley, N. Closing in on pancreatic beta cells. Nat Biotechnol 32, 1100–1102 (2014). https://doi.org/10.1038/nbt.3064
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3064
- Springer Nature America, Inc.
This article is cited by
-
Regenerative medicine: current research and perspective in pediatric surgery
Pediatric Surgery International (2023)
-
The quest to make fully functional human pancreatic beta cells from embryonic stem cells: climbing a mountain in the clouds
Diabetologia (2016)